Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/21452| Title: | Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Adult,Aged,Aged, 80 and over,Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use,Deoxycytidine/administration & dosage/adverse effects/analogs & derivatives,Doxorubicin/administration & dosage/adverse effects,Drug Administration Schedule,Drug Resistance, Multiple,Drug Resistance, Neoplasm,Female,Humans,Middle Aged,Organoplatinum Compounds/therapeutic use,Ovarian Neoplasms/*drug therapy,Taxoids/therapeutic use |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/21452 |
| ISSN: | 0250-7005 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/16080573 |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Pavlidis-2005-gemcitabine plus pegylated.pdf | 67.43 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
